Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Color Diagnostics, |
RCV001180057 | SCV001344906 | likely benign | Familial hypercholesterolemia | 2017-07-07 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001180057 | SCV001637685 | likely benign | Familial hypercholesterolemia | 2024-01-11 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002367702 | SCV002664182 | likely benign | Cardiovascular phenotype | 2022-08-03 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
All of Us Research Program, |
RCV000508876 | SCV004820197 | likely benign | Hypercholesterolemia, familial, 1 | 2023-12-18 | criteria provided, single submitter | clinical testing | |
Laboratorium voor Moleculaire Diagnostiek Experimentele Vasculaire Geneeskunde, |
RCV000508876 | SCV000606199 | benign | Hypercholesterolemia, familial, 1 | no assertion criteria provided | research | ||
Prevention |
RCV003942664 | SCV004761629 | likely benign | LDLR-related disorder | 2019-03-28 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |